Frontage Holdings (HKSE:01521) Tax Expense: HK$41 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01521 Frontage Holdings Corp HKSE:01521
91 GF Score
Price HK$1.20
GF Value HK$1.31
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Frontage Holdings Tax Expense?

Frontage Holdings HKSE:01521 +1.69% 91 Tax Expense is HK$41 Mil as of Jun. 2026. GuruFocus rates HKSE:01521 with a GF Score™ of 91/100 and a GF Value™ of HK$1.31 (Fairly Valued). The stock has 8 warning signs investors should review.

Frontage Holdings's tax expense for the months ended in Jun. 2026 was HK$21 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2026 was HK$41 Mil.


Frontage Holdings  (HKSE:01521) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Frontage Holdings Tax Expense Related Terms


Frontage Holdings Tax Expense Historical Data

* Premium members only.

The historical data trend for Frontage Holdings's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frontage Holdings Tax Expense Chart

Frontage Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.92 79.38 30.06 16.52 37.54

Frontage Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.44 11.10 17.14 20.55 20.94
HKSE:01521
91GF Score
Frontage Holdings Corp HKSE:01521
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Frontage Holdings Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of HK$41 Mil mean?
Frontage Holdings (HKSE:01521) has a Tax Expense of HK$41 Mil as of Jun. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Frontage Holdings and its competitors.
Is Frontage Holdings' Tax Expense too high?
Frontage Holdings' current Tax Expense is HK$41 Mil. Overall, Frontage Holdings has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Frontage Holdings' Tax Expense compare to VRTX and REGN?
Frontage Holdings' Tax Expense of HK$41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Biotechnology company?
A good Tax Expense depends on the Biotechnology industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Frontage Holdings and its competitors. Frontage Holdings's current Tax Expense is HK$41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontage Holdings stock overvalued right now?
Based on GuruFocus' analysis, Frontage Holdings (HKSE:01521) is currently considered Fairly Valued. The stock's GF Value™ is HK$1.31, compared to a current price of HK$1.20 — trading 8.4% below its estimated fair value. The current Tax Expense is HK$41 Mil. Frontage Holdings' overall GF Score™ is 91/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Frontage Holdings (HKSE:01521), the current Tax Expense is HK$41 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Frontage Holdings (HKSE:01521) Overvalued in 2026?

Based on GuruFocus' analysis, Frontage Holdings stock appears to be undervalued. The current stock price of HK$1.20 is trading 8.4% below its estimated GF Value™ of HK$1.31. GuruFocus considers Frontage Holdings to be Fairly Valued.

Key valuation signals for HKSE:01521:

  • Tax Expense: HK$41 Mil
  • GF Value™: HK$1.31 vs. price of HK$1.20 (8.4% below fair value)
  • GF Score™: 91/100 with 8 warning signs

No single metric tells the full story. See the HKSE:01521 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Frontage Holdings Business Description

Other Exchanges FGHQF:USA
Address 700 Pennsylvania Drive, Exton, PA, USA, 19341
Frontage Holdings Corp provides laboratory and related services to pharmaceutical and agrochemical companies. Its segments include North America and Europe segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the USA, Canada and Europe; and PRC segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the PRC. It derives majority of the revenue from North America and Europe segment. Geographically majority of the revenue is derived from USA and Canada.
91GF Score

Get the complete analysis for HKSE:01521

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.20
Price
HK$1.31
GF Value